Report of Foreign Issuer (6-k)
September 19 2018 - 3:18PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
W
ashington,
D.C.
20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
For the month of September 2018
Commission File Number: 001-37643
KITOV PHARMA
LTD.
(Translation of registrant's name into English)
One
Azrieli Center, Round Tower,
Tel
Aviv 6701101, Israel
(Address of principal executive offices)
Indicate by check mark
whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark
if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark
if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
On September 18, 2018, Kitov Pharma
Ltd.
(the “Company” or the “Registrant”) issued a Press Release: “
Kitov Pharma Updates on Motions in
USA Initiated by Kitov Chairman.
” A copy of this press release is furnished herewith as Exhibit 99.1.
This Form 6-K, including the entire Exhibit
99.1 attached hereto, are all hereby incorporated by reference into each of the Registrant’s Registration Statements on Form
F-3 filed with the Securities and Exchange Commission on December 12, 2016 (Registration file numbers 333-207117, 333-211477 and
333-215037), the Registrant’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on May
20, 2016 (Registration file number 333-211478), the Registrant’s Registration Statement on Form S-8 filed with the Securities
and Exchange Commission on June 6, 2017 (Registration file number 333-218538), and the Registrant’s Registration Statement
on Form F-3 filed with the Securities and Exchange Commission on July 16, 2018 (Registration file number 333-226195).
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
KITOV PHARMA LTD.
|
|
|
September 19, 2018
|
By:
|
/s/ Simcha Rock
|
|
|
Simcha Rock
|
|
|
CFO and Director
|
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Apr 2024 to May 2024
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From May 2023 to May 2024